DTIL
NASDAQ · Biotechnology
Precision Biosciences Inc
$7.94
-0.10 (-1.24%)
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+286.5% upside
Low Target
$21.79
Average Target
$30.69
High Target
$37.55
Current Price
$7.94
Current
$7.94
$7.94
Target
$30.69
$30.69
$21.79
$30.69 avg
$37.55
Scenario Analysis
Bear Case
$21.79
174.4%
Low target
Base Case
$30.69
+286.5%
Avg target
Bull Case
$37.55
+372.9%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$9.62
-17.5% from high
52-Week Low
$3.53
+124.9% from low
Target vs 52W High
$30.69
+219.0% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.5% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.9% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.2% |
| MRNA | Hold | 31 | 32% | $149.45 | -35.4% |
| REGN | Buy | 36 | 72% | $76.80 | -91.9% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.7% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -35.3% |